Atlas Trials

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Clinical trial NCT00586690 · COMPLETED

Trial details

NCT number
NCT00586690
Sponsor
David Rizzieri, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-05-01
Primary completion
2013-05-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.